3‐Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
3‐Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau
Authors
Keywords
-
Journal
YEAST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-22
DOI
10.1002/yea.3367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages
- (2018) Saveg Yadav et al. BIOMEDICINE & PHARMACOTHERAPY
- 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies
- (2018) Fangzheng Chen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
- (2018) Tomasz Jagielski et al. Frontiers in Pharmacology
- The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view
- (2017) Salah Mohamed El Sayed et al. MEDICAL HYPOTHESES
- 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
- (2017) Minjong Lee et al. PLoS One
- Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model
- (2016) Swathi Karthikeyan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Advances in understanding prognosis in myeloma
- (2016) Dean Smith et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis
- (2016) Christina Ramsenthaler et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
- (2016) J. Azevedo-Silva et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
- (2016) Paweł Lis et al. MOLECULES
- Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione
- (2016) Izabela Sadowska-Bartosz et al. Pharmacological Reports
- Non-secretory multiple myeloma: from biology to clinical management
- (2016) Megan Murray Dupuis et al. OncoTargets and Therapy
- Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
- (2016) Katarzyna Niedźwiecka et al. Oncotarget
- Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes
- (2016) Ricard Garcia-Carbonell et al. Arthritis & Rheumatology
- The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH
- (2015) João Azevedo-Silva et al. BIOCHEMICAL JOURNAL
- Smoldering multiple myeloma
- (2015) S. V. Rajkumar et al. BLOOD
- Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century
- (2015) Dianne Pulte et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells
- (2015) Ewa Kwiatkowska et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
- (2015) Yiming Sun et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein
- (2015) Jo Ishizawa et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
- (2015) Orkhan Isayev et al. Oncotarget
- The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions
- (2014) Matthew Glick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 119 3-Bromopyruvate as an inducer of immunogenic cell death in colon cancer cells
- (2014) K.H. Jung et al. EUROPEAN JOURNAL OF CANCER
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- 3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans
- (2013) Mariusz Dyląg et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of 3-bromopyruvic acid on human erythrocyte antioxidant defense system
- (2013) Izabela Sadowska-Bartosz et al. CELL BIOLOGY INTERNATIONAL
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Combination studies of platinum(ii)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin
- (2013) K. Benjamin Garbutcheon-Singh et al. Metallomics
- Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
- (2012) My Wintzell et al. CANCER BIOLOGY & THERAPY
- D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects
- (2012) S. M. El Sayed et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
- (2012) Y. H. Ko et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae
- (2012) Paweł Lis et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
- (2012) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias
- (2012) R. C. Walker et al. JOURNAL OF NUCLEAR MEDICINE
- Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
- (2011) M. Dimopoulos et al. BLOOD
- Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival
- (2011) Antonio Palumbo et al. CLINICAL CANCER RESEARCH
- The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil
- (2011) María Sánchez-Aragó et al. Journal of Translational Medicine
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- Inhibition of hexokinase leads to neuroprotection against excitotoxicity in organotypic hippocampal slice culture
- (2010) Kyung Hee Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate
- (2009) Muthusamy Thangaraju et al. CANCER
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model
- (2008) Xianhua Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells
- (2008) Ji Su Kim et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
- (2008) Saroj P. Mathupala et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More